Implantable devices that combine cardiac resynchronization therapy and defibrillation to reduce chronic heart failure events in patients with asymptomatic or mild to moderate heart failure (NYHA Class I/II).
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Dificid® (Fidaxomicin, Formerly OPT-80)
A first-in-class, narrow-spectrum, oral antibiotic for the treatment of Clostridium difficile-associated diarrhea, and prevention of recurrences.
Laquinimod
An oral immunomodulator for the treatment of relapsing remitting multiple sclerosis.
Ion™ Stent for Acute Myocardial Infarction
A paclitaxel-eluting, platinum chromium alloy stent intended for use in patients undergoing primary angioplasty to treat acute ST-segment elevation myocardial infarction.
Raven Mobile Surgical Robot
A mobile, lightweight, modular robotic surgical system designed to perform telesurgery over long distances.
Zelboraf® (Vemurafenib, PLX 4032)
An oral BRAF inhibitor for the treatment of late-stage metastatic melanoma with the gene mutation BRAF V600E.
Kalydeco™ (VX-770, Ivacaftor)
An oral cystic fibrosis transmembrane regulator potentiator for the treatment of cystic fibrosis in patients aged 6 years or older who have the rare G551D variant in the CFTR gene.
NanoKnife® System
A minimally invasive system that uses irreversible electroporation for surgical ablation of soft tissue.
LY3009104 (INCB028050)
An oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
Microsurgical Autologous Lymph Node Transfer (ALNT) for Postmastectomy Lymphedema
A microsurgical technique for the treatment of chronic refractory postmastectomy lymphedema, performed with or without concomitant breast reconstruction.